Full Text View
Tabular View
No Study Results Posted
Related Studies
Dacomitinib (PF-00299804) As A Single Oral Agent In Selected Patients With Adenocarcinoma Of The Lung
This study is ongoing, but not recruiting participants.
Study NCT00818441   Information provided by Pfizer

First Received on January 5, 2009.   Last Updated on October 28, 2014   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Additional conditions recognized in this trial
More general conditions related to this trial
Interventions listed in this trial
Sponsors listed in this trial